Prioritization of antimicrobial targets by CRISPR-based oligo recombineering
H. J. Benns, M. Storch, J. Falco, F. R. Fisher, E. Alves, C. J. Wincott, J. Baum, G. S. Baldwin, E. Weerapana, E. W. Tate, M. A. Child
This paper introduces CORe, a CRISPR-based method to prioritize reactive amino acids for drug discovery by linking sequence reactivity to protein function in Toxoplasma gondii.
bioRxiv · Feb 4, 2021Microbiology